Very poor long-term outcomes for people with TB and HIV in Eastern Europe
Social determinants of health result in staggering AIDS inequalities in Brazil
Long-acting injectable version of the most popular HIV drug combination is possible
The European AIDS Conference revisits Warsaw
PrEP use in pregnancy doesn't raise the risk of adverse pregnancy or birth outcomes
Past infection and vaccination protects against severe mpox
US study confirms no increased risk of neural tube defects after taking dolutegravir in pregnancy
Another class of cancer drugs may contribute to curing HIV
Users of TAF in PrEP more likely to develop high blood pressure or need statins
